SCHEMBL1961369

SCHEMBL1961369

O=S(=O)(c1ccc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)cc1)c1ccc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.59
CA12 O43570 2/20 0.58
CA2 P00918 2/20 0.58
CA9 Q16790 2/20 0.58
CA1 P00915 1/20 0.58
GAA P10253 2/20 0.52
ALDH1A1 P00352 1/20 0.52
LOX P28300 1/20 0.51
MMP1 P03956 3/20 0.49
MMP12 P39900 3/20 0.49
MMP2 P08253 3/20 0.49
MMP14 P50281 3/20 0.49
MMP3 P08254 2/20 0.49
MMP9 P14780 2/20 0.49
MMP8 P22894 2/20 0.49
MMP13 P45452 2/20 0.49
MMP16 P51512 2/20 0.49
MMP7 P09237 1/20 0.48
PTGS2 P35354 1/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958010 0.93 HTR6 (0.56) HTR6CA12CA2CA9CA1
SCHEMBL9001233 0.93 HTR6 (0.68) HTR6CA12CA2CA9CA1
SCHEMBL18194389 0.93 HTR6 (0.68) HTR6CA12CA2CA9CA1
(Phenylsulfonyl)Benzene SCHEMBL28196220 0.90 HTR6 (0.74) HTR6CA12CA2CA9CA1
SCHEMBL3026340 0.90 HTR6 (0.74) HTR6CA12CA2CA9CA1
SCHEMBL1961156 0.88 HTR6 (0.55) HTR6CA12CA2CA9CA1
SCHEMBL197508 0.87 HTR6 (0.78) HTR6CA12CA2CA9CA1
SCHEMBL18194388 0.86 HTR6 (0.61) HTR6CA12CA2CA9CA1
(Phenylsulfonyl)Benzene SCHEMBL2148473 0.85 HTR6 (0.82) HTR6CA12CA2CA9CA1
SCHEMBL3296279 0.82 ALDH1A1 (0.70) HTR6CA12CA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332907-B1 ORGANIC SULFUR COMPOUND, PROCESS FOR PRODUCTION OF THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT UTILIZING THE SAME UBE INDUSTRIES (JP) 2015-07-01 EP disclosed
EP-2332907-B1 ORGANIC SULFUR COMPOUND, PROCESS FOR PRODUCTION OF THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT UTILIZING THE SAME UBE INDUSTRIES (JP) 2015-07-01 EP disclosed
US-8597799-B2 Organosulfur compound, process for producing the same, and organic electroluminescence element using the same UBE INDUSTRIES, LTD. (JP) 2013-12-03 US disclosed
US-20110140044-A1 ORGANOSULFUR COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME UBE INDUSTRIES, LTD. (JP) 2011-06-16 US disclosed
US-20110140044-A1 ORGANOSULFUR COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME UBE INDUSTRIES, LTD. (JP) 2011-06-16 US disclosed
US-20110140044-A1 ORGANOSULFUR COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME UBE INDUSTRIES, LTD. (JP) 2011-06-16 US disclosed
EP-2332907-A1 ORGANIC SULFUR COMPOUND, PROCESS FOR PRODUCTION OF THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT UTILIZING THE SAME Ube Industries, Ltd. (JP) 2011-06-15 EP disclosed
EP-2332907-A1 ORGANIC SULFUR COMPOUND, PROCESS FOR PRODUCTION OF THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT UTILIZING THE SAME Ube Industries, Ltd. (JP) 2011-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110140044-A1 ORGANOSULFUR COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME AS3MT, ARSA, ASH2L HTR6 1526/4885CA12 4147/4885CA2 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.